openPR Logo

Press Releases from DelveInsight Business Research LLP (4878 total)

Parkinson's Disease Pipeline Outlook Report 2024 (Updated)

DelveInsight's, "Parkinson's Disease Pipeline Insight 2024" report provides comprehensive insights about 140+ companies and 150+ pipeline drugs in Parkinson's Disease pipeline landscape. It covers the

Non-Small Cell Lung Cancer Pipeline Outlook Report 2024 (Updated)

DelveInsight's, "Non-Small-Cell Lung cancer (NSCLC) Pipeline Insight 2024" report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in the Non-Small-Cell Lung cancer (NSCLC)

Advanced Renal Cell Carcinoma Pipeline Outlook Report 2024 (Updated)

DelveInsight's, "Advanced Renal Cell Carcinoma Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 60+ pipeline drugs in the Advanced Renal Cell Carcinoma

Advanced Ovarian Cancer Pipeline Outlook Report 2024 (Updated)

DelveInsight's, "Advanced Ovarian Cancer Pipeline Insight 2024" report provides comprehensive insights about 50+ Advanced Ovarian Cancer companies and 50+ Advanced Ovarian Cancer pipeline drugs in

Psoriatic Arthritis Pipeline Outlook Report 2024 (Updated)

DelveInsight's, "Psoriatic Arthritis Pipeline Insight 2024" report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in the Psoriatic Arthritis pipeline landscape. It covers

Psoriasis Pipeline Outlook Report 2024 (Updated)

DelveInsight's, "Psoriasis Pipeline Insight 2024" report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in the Psoriasis pipeline landscape. It covers the pipeline

Advanced Hepatocellular Carcinoma Pipeline Outlook Report 2024 (Updated)

DelveInsight's, "Advanced Hepatocellular Carcinoma Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in the Advanced Hepatocellular Carcinoma pipeline landscape.

Advanced Gastric Carcinoma Pipeline Outlook Report 2024 (Updated)

DelveInsight's, "Advanced Gastric Carcinoma Pipeline Insight, 2023," report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in the Advanced Gastric Carcinoma pipeline landscape.

Advanced Cervical Cancer Pipeline Outlook Report 2024 (Updated)

DelveInsight's, "Advanced Cervical Cancer Pipeline Insight 2024" report provides comprehensive insights about 70+ Advanced Cervical Cancer companies and 75+ Advanced Cervical Cancer pipeline drugs in

Encephalopathy Pipeline Outlook Report 2024 (Updated)

DelveInsight's, "Encephalopathy Pipeline Insight 2024" report provides comprehensive insights about 70+ Encephalopathy companies and 70+ pipeline drugs in the Encephalopathy pipeline landscape. It covers the

Encephalopathy Pipeline Outlook Report 2024 (Updated)

DelveInsight's, "Endometrial Cancer Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Endometrial Cancer pipeline landscape. It covers the

Functional Dyspepsia Market to Show a Rise During the Study Period | Takeda Phar …

DelveInsight's "Functional Dyspepsia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Functional Dyspepsia, historical and forecasted epidemiology as well as

Ependymoma Market to Show a Rise During the Study Period | Fera Pharmaceuticals, …

DelveInsight's "Ependymoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Ependymoma, historical and forecasted epidemiology as well as the Ependymoma

Chronic Spontaneous Urticaria Market to Show a Rise During the Study Period | Sa …

DelveInsight's "Chronic Spontaneous Urticaria Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Chronic Spontaneous Urticaria, historical and forecasted epidemiology as

Gender Dysphoria Market to Show a Rise During the Study Period | Valera Pharmace …

DelveInsight's "Gender Dysphoria Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Gender Dysphoria, historical and forecasted epidemiology as well as

Germany Healthcare Outlook Report 2023 by DelveInsight | Fresenius AG, Bayer AG, …

DelveInsight's "Germany Healthcare Outlook Report, 2023," report provides comprehensive insights into the healthcare scenario, regulatory policies, and reimbursement landscape in Germany. The report also identifies

Biopsy Devices Pipeline Insight and Competitive Landscape 2023 | Biopsy Devices …

DelveInsight's "Biopsy Devices - Pipeline Insight and Competitive Landscape 2023," report provides comprehensive insights about 20+ companies and 23+ pipeline devices in the biopsy devices

Bacterial Conjunctivitis Market to Show a Rise During the Study Period | Boehrin …

DelveInsight's "Bacterial Conjunctivitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Bacterial Conjunctivitis, historical and forecasted epidemiology as well as

Infliximab Biosimilar Insights Report 2023 by DelveInsight | Celltrion, Pfizer, …

DelveInsight's "Infliximab Biosimilar Insight, 2023" report provides comprehensive insights about 35+ companies and 45+ marketed and pipeline drugs in Infliximab Biosimilars landscape. It covers the

Eosinophilic Asthma Market to Show a Rise During the Study Period | Teva Pharmac …

DelveInsight's "Eosinophilic Asthma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Eosinophilic Asthma, historical and forecasted epidemiology as well as

Cushing's Syndrome Market to Show a Rise During the Study Period | Corcept Thera …

DelveInsight's "Cushing's Syndrome Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Cushing's Syndrome, historical and forecasted epidemiology as well as

Dry Eye Disease Pipeline Outlook Report 2024 (Updated)

DelveInsight's, "Dry Eye Disease Pipeline Insight 2024" report provides comprehensive insights about 45+ Dry Eye Disease companies and 50+ Dry Eye Disease pipeline drugs in

Diabetic Retinopathy Pipeline Outlook Report 2024 (Updated)

DelveInsight's, "Diffuse Large B-Cell Lymphoma Pipeline Insight 2024" report provides comprehensive insights about 80+ Diffuse Large B Cell Lymphoma companies and 80+ Diffuse Large B

Diabetic Retinopathy Pipeline Outlook Report 2024 (Updated)

DelveInsight's, "Diabetic Retinopathy Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in the Diabetic Retinopathy pipeline landscape. It covers

Diabetic Macular Edema Pipeline Outlook Report 2024 (Updated)

DelveInsight's, "Diabetic Macular Edema Pipeline Insight 2024" report provides comprehensive insights about 60+ Diabetic Macular Edema companies and 65+ Diabetic Macular Edema pipeline drugs in

Chronic Obstructive Pulmonary Disease Pipeline Outlook Report 2024 (Updated)

DelveInsight's, "Chronic Obstructive Pulmonary Disease Pipeline Insight 2024" report provides comprehensive insights about 65+ companies and 70+ pipeline drugs in Chronic Obstructive Pulmonary Disease pipeline

Chronic Lymphocytic Leukemia Pipeline Outlook Report 2024 (Updated)

DelveInsight's, "Chronic Lymphocytic Leukemia Pipeline Insight 2024" report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Chronic Lymphocytic Leukemia pipeline landscape. It

Chronic Hepatitis B Virus Pipeline Outlook Report 2024 (Updated)

DelveInsight's, "Chronic Hepatitis B Virus Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in Chronic Hepatitis B Virus pipeline

Cholangiocarcinoma Pipeline Outlook Report 2024 (Updated)

DelveInsight's, "Cholangiocarcinoma Pipeline Insight 2024" report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Cholangiocarcinoma pipeline landscape. It covers the Cholangiocarcinoma pipeline

Cervical Cancer Pipeline Outlook Report 2024 (Updated)

DelveInsight's, "Cervical Cancer Pipeline Insight 2024" report provides comprehensive insights about 70+ companies and 70+ pipeline drugs in Cervical Cancer pipeline landscape. It covers the

Brain Metastases Pipeline Outlook Report 2024 (Updated)

DelveInsight's, "Brain Metastases Pipeline Insight 2024" report provides comprehensive insights about 40+ Brain Metastases companies and 45+ pipeline drugs in the Brain Metastases pipeline landscape.

Acute Respiratory Distress Syndrome Pipeline Outlook Report 2024 (Updated)

DelveInsight's, "Acute Respiratory Distress Syndrome Pipeline Insight, 2024," report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Acute Respiratory Distress Syndrome pipeline

Wet Age-Related Macular Degeneration Pipeline Outlook Report 2024 (Updated)

DelveInsight's, "Wet Age-Related Macular Degeneration (Wet-AMD) Pipeline Insight, 2024" report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Wet Age-Related Macular Degeneration

Ulcerative Colitis Pipeline Outlook Report 2024 (Updated)

DelveInsight's, "Ulcerative Colitis Pipeline Insight 2024" report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in Ulcerative Colitis (UC) pipeline landscape. It covers

Type 1 Diabetes Pipeline Outlook Report 2024 (Updated)

DelveInsight's, "Type 1 Diabetes Pipeline Insight 2024" report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in the Type 1 Diabetes pipeline landscape.

Triple Negative Breast Cancer Pipeline Outlook Report 2024 (Updated)

DelveInsight's, "Triple Negative Breast Cancer Pipeline Insight 2024" report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Triple Negative Breast Cancer pipeline

TCR Therapy Pipeline Outlook Report 2024

DelveInsight's, "TCR Therapy Pipeline Insight 2024" report provides comprehensive insights about 30+ companies and 100+ pipeline drugs in the TCR Therapy pipeline landscape. It covers

T-Cell Lymphoma Pipeline Outlook Report 2024

DelveInsight's, "T-Cell Lymphoma Pipeline Insight 2024" report provides comprehensive insights about 90+ companies and 90+ pipeline drugs in T-Cell Lymphoma pipeline landscape. It covers the

Soft Tissue Sarcoma Pipeline Outlook Report 2024

DelveInsight's, "Soft Tissue Sarcoma Pipeline Insight 2024" report provides comprehensive insights about 125+ companies and 130+ pipeline drugs in Soft Tissue Sarcoma pipeline landscape. It

Small lymphocytic lymphoma Pipeline Outlook Report 2024

DelveInsight's, "Small Lymphocytic Lymphoma Pipeline Insight 2024" report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in Small Lymphocytic Lymphoma pipeline landscape. It

Small Cell Lung Cancer Pipeline Outlook Report 2024

DelveInsight's, "Small Cell Lung Cancer Pipeline Insight 2024" report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in the Small Cell Lung Cancer

Rheumatoid Arthritis Pipeline Outlook Report 2024

DelveInsight's, "Rheumatoid Arthritis Pipeline Insight 2024" report provides comprehensive insights about 95+ companies and 100+ pipeline drugs in the Rheumatoid Arthritis pipeline landscape. It covers

Renal Cell Carcinoma Pipeline Outlook Report 2024

DelveInsight's, "Renal Cell Carcinoma Pipeline Insight 2024" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Renal Cell Carcinoma pipeline landscape. It

Powered Surgical Instruments Market to Showcase Growth in the Upcoming Years | S …

The global market for powered surgical instruments reached a value of USD 2.06 billion in 2021 and is projected to expand at a compound annual

Renal Cancer Pipeline Outlook Report 2024

DelveInsight's, "Renal Cancer Pipeline Insight 2024" report provides comprehensive insights about 75+ Renal Cancer companies and 80+ pipeline drugs in the Renal Cancer pipeline landscape.

Orthopedic Prosthesis Devices Market to Showcase Growth in the Upcoming Years | …

The worldwide market for orthopedic prosthesis devices reached a valuation of USD 2.22 billion in 2021 and is projected to expand at a compound annual

Burn Pain Market to Show a Rise During the Study Period | MediWound Germany GmbH …

DelveInsight's "Burn Pain Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Burn Pain, historical and forecasted epidemiology as well as

Chemotherapy-induced Hearing Loss Market to Show a Rise During the Study Period …

DelveInsight's "Chemotherapy-induced Hearing Loss Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Chemotherapy-induced Hearing Loss, historical and foreacasted epidemiology as

Chiari Malformation Market to Show a Rise During the Study Period | Pfizer Inc., …

DelveInsight's "Chiari Malformation Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Chiari Malformation, historical and forecasted epidemiology as well as

Relapsed/Refractory Acute Myeloid Leukemia Pipeline Outlook Report 2024

DelveInsight's, "Relapsed/refractory acute myeloid leukemia (AML) Pipeline Insight, 2024" report provides comprehensive insights about 50+ companies and 75+ pipeline drugs in Relapsed/refractory acute myeloid leukemia

Go To Page:    51 52 53 54 55 56 57 58 59 60